← All trials
NCT02705482
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 30, 2016
- Primary completion
- Aug 11, 2020
- Completion date
- Apr 21, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 404
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- MedImmuneLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.